Challenges in the Treatment of Patients Coinfected with HIV and Hepatitis C Virus: Need for Team Care

We estimate that only one-third of patients coinfected with hepatitis C virus (HCV) and human immunodeficiency virus (HIV) are eligible for therapy for HCV with interferon (IFN) and ribavirin, and, of those who are eligible, two-thirds decline treatment. To date we have initiated treatment with IFN...

Full description

Saved in:
Bibliographic Details
Published in:Clinical infectious diseases 2005-04, Vol.40 (Supplement-5), p.S349-S354
Main Authors: Fleming, Catherine A., Tumilty, Sheila, Murray, Jessica E., Nunes, David
Format: Article
Language:English
Subjects:
AIDS
Biological and medical sciences
Boston
Cohort Studies
Coinfection
Delivery of Health Care, Integrated - organization & administration
Demography
Drug therapy
Eligibility Determination - standards
Health Services Accessibility
Hepacivirus
Hepatitis
Hepatitis C
Hepatitis C - complications
Hepatitis C - therapy
Hepatitis C virus
HIV
HIV Infections - complications
HIV Infections - therapy
Human immunodeficiency virus
Human viral diseases
Humans
Infections
Infectious diseases
Injections
Interferons - therapeutic use
Liver diseases
Medical sciences
Medical treatment
Mental illness
Outpatient Clinics, Hospital
Patients
Treatment Outcome
Viral diseases
Viral diseases of the digestive system
Viral diseases of the lymphoid tissue and the blood. Aids
Viral hepatitis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We estimate that only one-third of patients coinfected with hepatitis C virus (HCV) and human immunodeficiency virus (HIV) are eligible for therapy for HCV with interferon (IFN) and ribavirin, and, of those who are eligible, two-thirds decline treatment. To date we have initiated treatment with IFN and ribavirin for 8% of coinfected patients evaluated, and
ISSN:1058-4838
1537-6591
DOI:10.1086/427452